Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1)
- DOI
- 10.1038/s41420-026-03120-z
- Published
- 2026-04-13
- Container
- Cell Death Discovery
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41420-026-03120-z,
title = {Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1)},
author = {Olga S. Belozor and Alexandra G. Mileiko and Lyudmila D. Mosina and Ilya G. Mikhailov and Milana S. Mikhailova and Elena D. Khilazeva and Darius A. Ox and Egor S. Grinev and Elizaveta B. Boitsova and Andrey N. Shuvaev and Anja G. Teschemacher and Sergey Kasparov and Anton N. Shuvaev},
year = {2026},
journal = {Cell Death Discovery},
doi = {10.1038/s41420-026-03120-z},
url = {https://doi.org/10.1038/s41420-026-03120-z}
}RIS
TY - JOUR TI - Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1) AU - Olga S. Belozor AU - Alexandra G. Mileiko AU - Lyudmila D. Mosina AU - Ilya G. Mikhailov AU - Milana S. Mikhailova AU - Elena D. Khilazeva AU - Darius A. Ox AU - Egor S. Grinev AU - Elizaveta B. Boitsova AU - Andrey N. Shuvaev AU - Anja G. Teschemacher AU - Sergey Kasparov AU - Anton N. Shuvaev PY - 2026 JO - Cell Death Discovery DO - 10.1038/s41420-026-03120-z UR - https://doi.org/10.1038/s41420-026-03120-z ER -
APA
Belozor, O. S., Mileiko, A. G., Mosina, L. D., Mikhailov, I. G., Mikhailova, M. S., Khilazeva, E. D., Ox, D. A., Grinev, E. S., Boitsova, E. B., Shuvaev, A. N., Teschemacher, A. G., Kasparov, S., & Shuvaev, A. N. (2026). Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1). Cell Death Discovery. https://doi.org/10.1038/s41420-026-03120-z
Source records
- crossref · retrieved 2026-09-26T16:00:30.482Z